This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Iyer, R. K. Articles by Cederbaum, S. D. Search for Related Content PubMed PubMed Citation Articles by Iyer, R. K. Articles by Cederbaum, S. D.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, July 2002, p. 4491-4498, Vol. 22, No. 13
0270-7306/02/$04.00+0     DOI: 10.1128/MCB.22.13.4491-4498.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Mouse Model for Human Arginase Deficiency

Departments of Pathology and Laboratory Medicine,¹ Psychiatry,³ Pediatrics,⁵ the Mental Retardation Research Center, University of California Los Angeles School of Medicine, Los Angeles, California,² Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas⁴

Received 8 October 2001/ Returned for modification 16 November 2001/ Accepted 26 March 2002

Deficiency of liver arginase (AI) causes hyperargininemia (OMIM 207800), a disorder characterized by progressive mental impairment, growth retardation, and spasticity and punctuated by sometimes fatal episodes of hyperammonemia. We constructed a knockout mouse strain carrying a nonfunctional AI gene by homologous recombination. Arginase AI knockout mice completely lacked liver arginase (AI) activity, exhibited severe symptoms of hyperammonemia, and died between postnatal days 10 and 14. During hyperammonemic crisis, plasma ammonia levels of these mice increased >10-fold compared to those for normal animals. Livers of AI-deficient animals showed hepatocyte abnormalities, including cell swelling and inclusions. Plasma amino acid analysis showed the mean arginine level in knockouts to be approximately fourfold greater than that for the wild type and threefold greater than that for heterozygotes; the mean proline level was approximately one-third and the ornithine level was one-half of the proline and ornithine levels, respectively, for wild-type or heterozygote mice—understandable biochemical consequences of arginase deficiency. Glutamic acid, citrulline, and histidine levels were about 1.5-fold higher than those seen in the phenotypically normal animals. Concentrations of the branched-chain amino acids valine, isoleucine, and leucine were 0.4 to 0.5 times the concentrations seen in phenotypically normal animals. In summary, the AI-deficient mouse duplicates several pathobiological aspects of the human condition and should prove to be a useful model for further study of the disease mechanism(s) and to explore treatment options, such as pharmaceutical administration of sodium phenylbutyrate and/or ornithine and development of gene therapy protocols.

This article has been cited by other articles:

• Vanhoutte, P. M. (2008). Arginine and Arginase: Endothelial NO Synthase Double Crossed?. Circ. Res. 102: 866-868 [Full Text]  
• Deignan, J. L., Livesay, J. C., Shantz, L. M., Pegg, A. E., O'Brien, W. E., Iyer, R. K., Cederbaum, S. D., Grody, W. W. (2007). Polyamine homeostasis in arginase knockout mice. Am. J. Physiol. Cell Physiol. 293: C1296-C1301 [Abstract] [Full Text]  
• Chaturvedi, R., Asim, M., Lewis, N. D., Algood, H. M. S., Cover, T. L., Kim, P. Y., Wilson, K. T. (2007). L-Arginine Availability Regulates Inducible Nitric Oxide Synthase-Dependent Host Defense against Helicobacter pylori. Infect. Immun. 75: 4305-4315 [Abstract] [Full Text]  
• Marathe, C., Bradley, M. N., Hong, C., Lopez, F., de Galarreta, C. M. R., Tontonoz, P., Castrillo, A. (2006). The Arginase II Gene Is an Anti-inflammatory Target of Liver X Receptor in Macrophages. J. Biol. Chem. 281: 32197-32206 [Abstract] [Full Text]  
• Yang, B., Zhao, D., Solenov, E., Verkman, A. S. (2006). Evidence from knockout mice against physiologically significant aquaporin 8-facilitated ammonia transport. Am. J. Physiol. Cell Physiol. 291: C417-C423 [Abstract] [Full Text]  
• White, A. R., Ryoo, S., Li, D., Champion, H. C., Steppan, J., Wang, D., Nyhan, D., Shoukas, A. A., Hare, J. M., Berkowitz, D. E. (2006). Knockdown of Arginase I Restores NO Signaling in the Vasculature of Old Rats. Hypertension 47: 245-251 [Abstract] [Full Text]  
• Munder, M., Mollinedo, F., Calafat, J., Canchado, J., Gil-Lamaignere, C., Fuentes, J. M., Luckner, C., Doschko, G., Soler, G., Eichmann, K., Muller, F.-M., Ho, A. D., Goerner, M., Modolell, M. (2005). Arginase I is constitutively expressed in human granulocytes and participates in fungicidal activity. Blood 105: 2549-2556 [Abstract] [Full Text]  
• Scaglia, F., Brunetti-Pierri, N., Kleppe, S., Marini, J., Carter, S., Garlick, P., Jahoor, F., O'Brien, W., Lee, B. (2004). Clinical Consequences of Urea Cycle Enzyme Deficiencies and Potential Links to Arginine and Nitric Oxide Metabolism. J. Nutr. 134: 2775S-2782S [Abstract] [Full Text]  
• King, N. E., Rothenberg, M. E., Zimmermann, N. (2004). Arginine in Asthma and Lung Inflammation. J. Nutr. 134: 2830S-2836S [Abstract] [Full Text]  
• Conjard, A., Komaty, O., Delage, H., Boghossian, M., Martin, M., Ferrier, B., Baverel, G. (2003). Inhibition of Glutamine Synthetase in the Mouse Kidney: A NOVEL MECHANISM OF ADAPTATION TO METABOLIC ACIDOSIS. J. Biol. Chem. 278: 38159-38166 [Abstract] [Full Text]  
• Endo, M., Oyadomari, S., Terasaki, Y., Takeya, M., Suga, M., Mori, M., Gotoh, T. (2003). Induction of arginase I and II in bleomycin-induced fibrosis of mouse lung. Am. J. Physiol. Lung Cell. Mol. Physiol. 285: L313-L321 [Abstract] [Full Text]